MALAT1 and lung carcinoma: In addition to targeting the protein-coding mRNAs, ASO targeting lncRNA MALAT1 dramatically prevented lung cancer metastasis in a pulmonary metastatic mouse model (Gutschner et al., 2013), showing attractive potentials for developing ASO drugs targeting functional ncRNAs to treat PCa.